News Release: March 16, 1998

PATIENT: Richard Hughes, 52 years old, who lives in Albuquerque, an architect

DOCTORS: Carl Lagerstrom, M.D. and Chris Wehr, M.D., cardiothoracic surgeons with Presbyterian Heart Group performed the surgery for the first time in New Mexico.

WHAT: The stentless Toronto SPVâ valve was just approved by the FDA last month. The valve lasts at least 5 - 10 years longer than other valves (excluding mechanical valves). Patients will no longer need to take Coumadin, a prescription drug that affects lifestyle and has side affects.

WHERE: The surgery was performed at Presbyterian Hospital

WHEN: Tuesday, January 27, 1998 WHY: Mr. Hughes is a very active person and did not want to deal with the effects of taking Coumadin. Most valves are reserved for people who are older because the valves do not last that long. Mr. Hughes is an ideal candidate because he is younger and the valve will last longer.

INTERVIEW OPPORTUNITIES:

• Richard Hughes
• Carl Lagerstrom, M.D.
• Chris Wehr, M.D.

CONTACT: Claire Catanach, 260-6583